Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada

• Autores principales: Virender Bhan (Autor), Fraser Clift (Autor), Moogeh Baharnoori (Autor), Kimberly Thomas (Autor), Barkha P Patel (Autor), Francois Blanchette (Autor), Nicholas Adlard (Autor), Umakanth Vudumula (Autor), Kapil Gudala (Autor), Nikkita Dutta (Autor), Daniel Grima (Autor), Soukaina Mouallif (Autor), Fatine Farhane (Autor)
• Formato: Libro
• Publicado: Becaris Publishing Limited, 2023-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Aim: The costs and consequences of initial and delayed ofatumumab treatment were evaluated in relapsing-remitting multiple sclerosis with active disease in Canada. Materials & methods: A Markov cohort model was used (10-year horizon, annual cycle length, 1.5% discounting). Scenario analyses exam...